<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01080859</url>
  </required_header>
  <id_info>
    <org_study_id>SA-004</org_study_id>
    <nct_id>NCT01080859</nct_id>
  </id_info>
  <brief_title>Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Assessed By Optical Coherence Tomography</brief_title>
  <acronym>BASE-OCT</acronym>
  <official_title>Early Coverage and Vessel Wall Response of the Bio-Active-stent and Everolimus-Eluting Stent Implanted in Acute Coronary Syndrome Assessed By Optical Coherence Tomography (BASE-OCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital District of Satakunta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital District of Satakunta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the trial is to evaluate the completeness of struts coverage and vessel wall
      response (strut malapposition, neoin-timal formation) to the bio-active-stent (BAS) versus
      ever-olimus-eluting stent (EES) implanted for the treatment of the culprit lesion in acute
      coronary syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, randomized and controlled study comparing the coverage of the BAS and EES
      implanted in acute coronary syndrome.

      Clinical follow-up at 1, 6, 12 and 18 months. OCT analysis at the time of the 6 to 8 months
      follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Uncovered stent struts</measure>
    <time_frame>6-8 months</time_frame>
    <description>OCT number of uncovered stent struts for BAS versus EES.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac death,MI, stent thrombosis (ST) and TLR.</measure>
    <time_frame>1, 6, 12 and 18 months</time_frame>
    <description>Device oriented composite endpoint, defined as cardiac death,MI, stent thrombosis (ST) and TLR at at 1, 6, 12 and 18 months.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>BAS</arm_group_label>
    <description>Patient's receiving BAS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EES</arm_group_label>
    <description>Patients receiving EES</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT</intervention_name>
    <description>Optical coherence tomography</description>
    <arm_group_label>BAS</arm_group_label>
    <other_name>TITAN-2, Hexacath, France</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT</intervention_name>
    <description>Optical coherence tomography</description>
    <arm_group_label>EES</arm_group_label>
    <other_name>Xience-V, Abbott vascular, USA</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting with acute coronary syndrome and who were treated either BAS or EES
        during the index PCI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is â‰¥ 18 years old;

          -  The patient is presenting with acute coronary syndrome, and according to hospital
             routine practice, eligible for percutaneous coronary intervention;

          -  Patient or the patient's legal representative has been informed of the nature of the
             study and has provided written informed consent as approved by the Institutional
             Ethics Committee of the respective clinical site.

        Exclusion Criteria:

          -  Lesions in coronary artery bypass grafts

          -  Left main disease

          -  Killip class III-IV

          -  Allergy to aspirin / thienopyridine

          -  Patient in anticoagulation therapy

          -  No suitable anatomy for OCT scan

          -  Ostial lesion

          -  Tortuosity anatomy

          -  Very distal lesion

          -  Vessel size &gt; 3.75 mm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pasi P Karjalainen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Satakunta Central Hospital, Pori, Finland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antti Ylitalo, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Satakunta Central Hospital, Pori, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <zip>28500</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2010</study_first_submitted>
  <study_first_submitted_qc>March 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2010</study_first_posted>
  <last_update_submitted>May 4, 2011</last_update_submitted>
  <last_update_submitted_qc>May 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Satakun Hospital District</name_title>
    <organization>Satakunta Central Hospital</organization>
  </responsible_party>
  <keyword>titanium</keyword>
  <keyword>everolimus</keyword>
  <keyword>oct</keyword>
  <keyword>acute coronary syndrome</keyword>
  <keyword>stent</keyword>
  <keyword>pci</keyword>
  <keyword>stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

